You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II

Citation Tools

Article menu

Download PDFPDF

Cervical cancer
2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Jullian N, Benkhaled S, Bellal S, et al
2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II
International Journal of Gynecologic Cancer 2022;32:A34.